These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25533234)

  • 1. [Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia].
    Andreoni M
    Recenti Prog Med; 2014 Dec; 105(12):462-8. PubMed ID: 25533234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
    Burgos J; Crespo M; Falcó V; Curran A; Navarro J; Imaz A; Domingo P; Podzamczer D; Mateo MG; Villar S; Van den Eynde E; Ribera E; Pahissa A
    J Antimicrob Chemother; 2012 Oct; 67(10):2479-86. PubMed ID: 22729925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and concerns of simplification strategies in HIV-infected patients.
    Negredo E; Bonjoch A; Clotet B
    J Antimicrob Chemother; 2006 Aug; 58(2):235-42. PubMed ID: 16807250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).
    Di Giambenedetto S; Fabbiani M; Colafigli M; Ciccarelli N; Farina S; Sidella L; D'Avino A; Mondi A; Cingolani A; Tamburrini E; Murri R; Navarra P; Cauda R; De Luca A
    J Antimicrob Chemother; 2013 Jun; 68(6):1364-72. PubMed ID: 23372058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
    Masquelier B; Pereira E; Peytavin G; Descamps D; Reynes J; Verdon R; Fleury H; Garraffo R; Chêne G; Raffi F; Brun-Vézinet F;
    J Clin Virol; 2005 May; 33(1):75-8. PubMed ID: 15797369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch strategies in antiretroviral therapy regimens.
    Van den Eynde E; Podzamczer D
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1055-74. PubMed ID: 25075752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Data on rilpivirine in treatment-naïve patients. Lessons from ECHO, THRIVE and STaR].
    Domingo P; Ribera E
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():20-9. PubMed ID: 24252530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy.
    Pulido F; Arribas JR; Hill A; Van Delft Y; Moecklinghoff C
    Antivir Ther; 2011; 16(1):59-65. PubMed ID: 21311109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch to abacavir-based triple nucleoside regimens in HIV-1 infected patients never treated with suboptimal antiretroviral therapy: a review.
    Rizzardini G; Capetti A
    Med Sci Monit; 2006 Dec; 12(12):RA269-276. PubMed ID: 17136016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequencing antiretroviral drugs for long-lasting suppression of HIV replication.
    Gianotti N; Lazzarin A
    New Microbiol; 2005 Oct; 28(4):281-97. PubMed ID: 16386013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and simplification of antiretroviral therapy for adults and children.
    Ford N; Flexner C; Vella S; Ripin D; Vitoria M
    Curr Opin HIV AIDS; 2013 Nov; 8(6):591-9. PubMed ID: 24100871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems in the management of HIV infection in clinical practice. Patients still on dual therapy 8 years after the introduction of HAART].
    Manfredi R
    Recenti Prog Med; 2003 Nov; 94(11):506-7. PubMed ID: 14679919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virologic suppression in treatment-experienced patients after virologic rebound or failure of therapy.
    Sarmento-Castro R; Vasconcelos C; Aguas MJ; Marques R; Oliveira J
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S12-20. PubMed ID: 22156775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
    Gulick RM; Lalama CM; Ribaudo HJ; Shikuma CM; Schackman BR; Schouten J; Squires KE; Koletar SL; Pilcher CD; Reichman RC; Klingman KL; Kuritzkes DR
    AIDS; 2007 Apr; 21(7):813-23. PubMed ID: 17415036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
    J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategies.
    Ferretti F; Gianotti N; Lazzarin A; Cinque P
    Semin Neurol; 2014 Feb; 34(1):78-88. PubMed ID: 24715491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful simplification of HAART in patients with acute primary HIV infection.
    Sinicco A; Bonora S; Arnaudo I; Zeme DA; Audagnotto S; Raiteri R; Di Perri G
    J Biol Regul Homeost Agents; 2002; 16(1):69-72. PubMed ID: 12003178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.